Literature DB >> 16004419

Direct, controlled synthesis of the nonimmunogenic, hydrophilic polymer, poly(N-(2-hydroxypropyl)methacrylamide) via RAFT in aqueous media.

Charles W Scales1, Yulia A Vasilieva, Anthony J Convertine, Andrew B Lowe, Charles L McCormick.   

Abstract

Poly(N-(2-hydroxypropyl)methacrylamide) (PHPMA) is a nonimmunogenic, neutral-hydrophilic polymer currently employed in the delivery of anticancer drugs. Herein, we report conditions that facilitate the direct, controlled RAFT polymerization of HPMA in aqueous media. We demonstrate that the use of 4-cyanopentanoic acid dithiobenzoate and 4,4'-azobis(4-cyanopentanoic acid) as the chain transfer agent (CTA) and initiating species, respectively, in the presence of an acetic acid buffer solution at 70 degrees C is a suitable condition leading to controlled polymerization. The "living" nature of these polymerizations is demonstrated via chain-extension of an HPMA macroCTA to yield the corresponding poly(HPMA-b-HPMA) "homopolymer".

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16004419     DOI: 10.1021/bm0503017

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  22 in total

Review 1.  Protein-polymer conjugation-moving beyond PEGylation.

Authors:  Yizhi Qi; Ashutosh Chilkoti
Journal:  Curr Opin Chem Biol       Date:  2015-09-07       Impact factor: 8.822

2.  Synthesis of Biodegradable Multiblock Copolymers by Click Coupling of RAFT-Generated HeterotelechelicPolyHPMA Conjugates.

Authors:  Jiyuan Yang; Kui Luo; Huaizhong Pan; Pavla Kopečková; Jindřich Kopeček
Journal:  React Funct Polym       Date:  2011-03-01       Impact factor: 3.975

3.  A tumor-targeted polymer theranostics platform for positron emission tomography and fluorescence imaging.

Authors:  Eva Koziolová; Shreya Goel; Petr Chytil; Olga Janoušková; Todd E Barnhart; Weibo Cai; Tomáš Etrych
Journal:  Nanoscale       Date:  2017-08-03       Impact factor: 7.790

4.  Poly(N-(2-Hydroxypropyl) Methacrylamide)-Valproic Acid Conjugates as Block Copolymer Nanocarriers.

Authors:  Jawaher A Alfurhood; Hao Sun; Christopher P Kabb; Bryan S Tucker; James H Matthews; Hendrik Luesch; Brent S Sumerlin
Journal:  Polym Chem       Date:  2017-02-22       Impact factor: 5.582

5.  The Light at the End of the Tunnel-Second Generation HPMA Conjugates for Cancer Treatment.

Authors:  Jiyuan Yang; Jindřich Kopeček
Journal:  Curr Opin Colloid Interface Sci       Date:  2017-07-28       Impact factor: 6.448

6.  Facile synthesis of multivalent folate-block copolymer conjugates via aqueous RAFT polymerization: targeted delivery of siRNA and subsequent gene suppression.

Authors:  Adam W York; Yilin Zhang; Andrew C Holley; Yanlin Guo; Faqing Huang; Charles L McCormick
Journal:  Biomacromolecules       Date:  2009-04-13       Impact factor: 6.988

Review 7.  Beyond oncology--application of HPMA copolymers in non-cancerous diseases.

Authors:  Xin-Ming Liu; Scott C Miller; Dong Wang
Journal:  Adv Drug Deliv Rev       Date:  2009-11-10       Impact factor: 15.470

8.  Self-assembling diblock copolymers of poly[N-(2-hydroxypropyl)methacrylamide] and a beta-sheet peptide.

Authors:  Larisa Cristina Radu; Jiyuan Yang; Jindrich Kopecek
Journal:  Macromol Biosci       Date:  2009-01-09       Impact factor: 4.979

9.  Intracellular delivery of a proapoptotic peptide via conjugation to a RAFT synthesized endosomolytic polymer.

Authors:  Craig L Duvall; Anthony J Convertine; Danielle S W Benoit; Allan S Hoffman; Patrick S Stayton
Journal:  Mol Pharm       Date:  2010-04-05       Impact factor: 4.939

Review 10.  Macromolecular therapeutics.

Authors:  Jiyuan Yang; Jindřich Kopeček
Journal:  J Control Release       Date:  2014-04-18       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.